CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Eleven Biotherapeutics, Inc.  (EBIO)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 
 

EBIO's Revenue Year on Year Growth by Quarter and Year

Eleven Biotherapeutics,'s Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
EBIO Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - -28.75 0.07 0.38
III Quarter September - 28.65 0.07 0.54
II Quarter June - 0.28 0.11 0.76
I Quarter March 0.43 0.23 0.24 0.57
FY   0.43 0.41 0.49 2.25

Financial Statements
Eleven Biotherapeutics,'s first quarter 2017 Revenue $ 0.43 millions EBIO's Income Statement
Eleven Biotherapeutics,'s first quarter 2016 Revenue $ 0.23 millions Quarterly EBIO's Income Statement
EBIO's Growth by Division See EBIO's Growth by Segment

EBIO Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - - -81.58 % -
III Quarter September - 40828.57 % -87.04 % -
II Quarter June - 154.55 % -85.53 % -
I Quarter March 84.78 % -4.17 % -57.89 % -
FY   - -16.33 % -78.22 % -



EBIO Revenue Growth Comment
Eleven Biotherapeutics, Inc. reported Revenue rise of 84.78% year on year in the first quarter, to $ 0.43 millions, this is lower than Eleven Biotherapeutics, Inc.'s recent average Revenue surge of 5321.42%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 21 other companies have achieved higher Revenue growth. While Eleven Biotherapeutics, Inc.' s Revenue jump of 84.78% ranks overall at the positon no. 283 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #22
Healthcare Sector #59
S&P 500 #283
Revenue Y/Y Growth Statistics
High Average Low
42661.19 % 5321.42 % -87.57 %
(Sep 30 2016)   (Sep 30 2015)

You need to upgrade your Flash Player

Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EBIO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EBIO's Competitors
Revenue Growth for Eleven Biotherapeutics,'s Suppliers
Revenue Growth for EBIO's Customers

You may also want to know
EBIO's Annual Growth Rates EBIO's Profitability Ratios EBIO's Asset Turnover Ratio EBIO's Dividend Growth
EBIO's Roe EBIO's Valuation Ratios EBIO's Financial Strength Ratios EBIO's Dividend Payout Ratio
EBIO's Roa EBIO's Inventory Turnover Ratio EBIO's Growth Rates EBIO's Dividend Comparisons



Companies with similar Revenue jump for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Viveve Medical, Inc.  136.84 %$ 136.838 millions
Flex Pharma, Inc.  134.72 %$ 134.724 millions
China Longyi Group International Holdings Ltd  126.39 %$ 126.388 millions
Neos Therapeutics, Inc.  117.85 %$ 117.847 millions
Hemispherx Biopharma Inc  115.38 %$ 115.385 millions
Novabay Pharmaceuticals, Inc.  115.30 %$ 115.300 millions
Aveo Pharmaceuticals Inc  110.47 %$ 110.474 millions
Egalet Corp  103.79 %$ 103.793 millions
Delcath Systems, Inc.  100.81 %$ 100.811 millions
Green Meadow Products, Inc.  100.00 %$ 100.000 millions
Uluru Inc.  99.57 %$ 99.571 millions
Juno Therapeutics, Inc.  97.72 %$ 97.719 millions
Biocryst Pharmaceuticals Inc  95.79 %$ 95.788 millions
Kite Pharma, Inc.  91.85 %$ 91.847 millions
Neurometrix, Inc.  89.26 %$ 89.260 millions
Eleven Biotherapeutics, Inc.  85.59 %$ 85.590 millions
Nantkwest, Inc.  83.33 %$ 83.333 millions
Psivida Corp.  82.10 %$ 82.099 millions
Cempra, Inc.  81.86 %$ 81.859 millions
Vertex Pharmaceuticals Inc  79.54 %$ 79.541 millions
Ani Pharmaceuticals Inc  78.20 %$ 78.195 millions
Vivus Inc  76.27 %$ 76.273 millions
Anavex Life Sciences Corp.  73.19 %$ 73.195 millions
Keryx Biopharmaceuticals Inc  73.17 %$ 73.172 millions
Cytosorbents Corp  72.00 %$ 72.000 millions
Corcept Therapeutics Inc  71.84 %$ 71.839 millions
Advanced Medical Isotope Corp  69.07 %$ 69.068 millions
Innoviva, Inc.  67.49 %$ 67.488 millions
Presbia Plc  66.67 %$ 66.667 millions
Intelgenx Technologies Corp.  65.40 %$ 65.403 millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com